Follow-up for safety after multiple FURESTEM-AD doses
Part of Genetic & congenital, Immune system & allergy, Skin clinical trials.
This study is checking long-term safety after people received FURESTEM-AD in an earlier trial, and it also looks for early signs of whether repeated doses might help. It may help researchers understand the risks over time and whether the treatment could work better with multiple doses.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You took part in the earlier K0104 clinical trial (the parent study).
- You can understand the study details and agree by signing informed consent.
- You are able and willing to attend follow-up visits (at least one) during this study.
- You did not receive other clinical-trial drugs or medical devices from other studies until your first visit here.
- The study team believes you are a good fit to participate.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows adults with moderate to severe eczema who are eligible for or already taking systemic (pill or injection) medicines. It does not test any new drug—it simply tracks how eczema is managed in real life, which may help improve future care.
This trial tests a new ointment called CU-10101. It will first be tested in healthy volunteers to check safety, and then in people with atopic dermatitis (eczema) to see how well it works for mild to moderate symptoms.
This trial is testing a new investigational medicine (PF-07832837) for safety in healthy adults and in people with moderate to severe atopic dermatitis (eczema). It is a first-in-human study, so it looks at how well the body tolerates the medicine.
This study is a real-world registry that collects information from adults with atopic dermatitis (eczema) to track how newly started treatments work and how safe they are over time. It may help researchers and doctors better understand medication effects in everyday care.
This study is a long-term registry for adolescents and adults with atopic dermatitis (eczema) who are starting or switching to a systemic medication (a drug that works throughout the body). It will track how these treatments work in real life and how patients feel over time.
This trial tests a study drug (PF-08049820) for people with moderate to severe eczema who haven't found a suitable prescription treatment. It aims to see if the drug can improve skin symptoms and itching.
Hear when a new Atopic Dermatitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.